| answer text |
<p>The Joint Committee on Vaccination and Immunisation (JCVI) published interim advice
on a potential COVID-19 booster vaccination programme on 30 June, which is available
at the following link:</p><p><a href="https://www.gov.uk/government/publications/jcvi-interim-advice-on-a-potential-coronavirus-covid-19-booster-vaccine-programme-for-winter-2021-to-2022"
target="_blank">https://www.gov.uk/government/publications/jcvi-interim-advice-on-a-potential-coronavirus-covid-19-booster-vaccine-programme-for-winter-2021-to-2022</a></p><p>The
JCVI advises a two staged approach, with individuals in stage one offered a booster
and flu vaccine, as soon as possible from September. Individuals in stage two should
be offered a booster vaccine as soon as practicable after stage one, with equal emphasis
on deployment of the flu vaccine where eligible. Adults aged over 50 years old and
those aged 16 to 49 years old who are in an influenza or COVID-19 at-risk group, are
included in stage two. Influenza at-risk groups include some sufferers of chronic
respiratory disease, such as asthma.</p><p>Final decisions on the timing and scope
of the vaccine booster programme, as well as cohorts and eligibility, will be made
later in the year, informed by further independent advice from the JCVI.</p>
|
|
